SysChem Announces Amino Acid Patent Pending

SysChem has perfected a process for the Conversion of Amino Acid Hydrochlorides to their Free Base Forms and has applied for patent protection for its breakthrough.

R&D Director Robert Bunn developed the process using SystematiChem©, SysChem’s proprietary retrosynthesis software.

SysChem’s CEO Richard A. Wueste says the Amino Acid Patent Pending marks a new direction for SysChem.  “Our primary product has will always be custom synthesis of molecules selected by our customers.  The efficiency of SystematiChem© allows us to independently develop novel syntheses, patent them, and offer a perfected pathway for license or outright sale,” Wueste said. “By offering perfected least-cost pathways, SysChem can provide a client with instant entry to a market it may not have considered before.”